Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)
Close on Nov 18, 2026Market cap $593.30MP/E –Yield –
Sight Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Sight Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$23.24M. For fiscal 2025 it was -$29.69M. The highest annual figure on record is -$22.35M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.69M | – |
| FY2024 | Dec 31, 2024 | -$22.35M | – |
| FY2023 | Dec 31, 2023 | -$47.18M | – |
| FY2022 | Dec 31, 2022 | -$75.97M | – |
| FY2021 | Dec 31, 2021 | -$52.54M | – |
| FY2020 | Dec 31, 2020 | -$32.17M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.66M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.03M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.83M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.72M | -2508.6% |
| Q2 FY2025 | Jun 30, 2025 | -$7.54M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.61M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.46M | – |
| Q3 FY2024 | Sep 30, 2024 | $362.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.47M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.79M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.83M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.49M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.50M | – |
| Q3 FY2022 | Sep 30, 2022 | -$20.19M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.31M | – |
| Q1 FY2022 | Mar 31, 2022 | -$21.97M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.72M | – |
| Q3 FY2021 | Sep 30, 2021 | -$16.51M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.44M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.87M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.55M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.62M | – |
See a number that looks wrong?